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The characteristics, importance, and molecular
requirements for interactions between mast cells
(MCs) and CD8+ T cells have not been elucidated.
Here, we demonstrated that MCs induced antigen-
specific CD8+ T cell activation and proliferation.
This process required direct cell contact and MHC
class I-dependent antigen cross-presentation by
MCs and induced the secretion of interleukin-2, inter-
feron-g, and macrophage inflammatory protein-1a
by CD8+ T cells. MCs regulated antigen-specific
CD8+ T cell cytotoxicity by increasing granzyme B
expression and by promoting CD8+ T cell degranula-
tion. Because MCs also upregulated their expression
of costimulatory molecules (4-1BB) and released os-
teopontin upon direct T cell contact, MC-T cell inter-
actions probably are bidirectional. In vivo, adoptive
transfer of antigen-pulsed MCs induced MHC class
I-dependent, antigen-specific CD8+ T cell prolifera-
tion, and MCs regulated CD8+ T cell-specific priming
in experimental autoimmune encephalomyelitis.
Thus, MCs are important players in antigen-specific
regulation of CD8+ T cells.
INTRODUCTION
Mast cells (MCs) are well recognized as key effector cells in
immunoglobulin E (IgE)-associated immune responses and as
prototypic regulators of innate immunity (Marshall, 2004; Metz
and Maurer, 2007; Orinska et al., 2007; Galli et al., 2008).
However, evidence that MCs also play an important regulatory
role in adaptive immunity is steadily accumulating (Galli et al.,
2005; Stelekati et al., 2007; Sayed et al., 2008). For example,
MCs modulate the phenotype and function of adaptive immunity
protagonists, such as B cells, dendritic cells (DCs), and T cells
via direct cell contact, release of exosomes, or secretion of soluble
factors (Caronet al., 2001;Gauchatet al., 1993;Kashiwakura et al.,
2004; Nakae et al., 2005; Skokos et al., 2003; Tkaczyk et al., 2000).MCs actively regulate T cell migration. MCs can migrate from
the site of allergen encounter to the draining lymph nodes, in
which they recruit T cells (Wang et al., 1998). MCs also recruit
T cells at peripheral sites of inflammation by secreting chemo-
tactic molecules, such as MIP-1b, RANTES, and interleukin-16
(IL-16) (Burd et al., 1989; Okumura et al., 2003; Rumsaeng
et al., 1997). MC-derived tumor necrosis factor-a (TNF-a)
induces chemotaxis of circulating T cells into the draining lymph
nodes during bacterial infection (McLachlan et al., 2003). Fc3RI-
mediated degranulation of MCs results in chemotaxis of effector
CD8+ T cells via leukotriene B4 (LTB4) secretion (Ott et al., 2003).
CD8+ T cell recruitment is also induced upon Toll-like receptor 3
(TLR3)-dependent activation ofMCs in vivo (Orinska et al., 2005).
Collectively, this evidence suggests that MCs regulate a wide, as
yet to be elucidated range of MC-CD8+ T cell functions.
The concept that MCs may induce T cell responses initially
arose after the observation that cultured MC progenitors and
primary MCs (Wong et al., 1982; Banovac et al., 1989) can
express surface and intracellular major histocompatibility com-
plex (MHC) class II molecules. Subsequently, MHC class II and
expression of costimulatory molecules was detected on mouse,
rat, and human MCs. MCs were shown to induce proliferation of
CD4+ T cell lines upon presentation of MHC class II-restricted
antigens in vitro (Fox et al., 1994; Frandji et al., 1993; Poncet
et al., 1999) as well as proliferation of a CD8+ T cell hybridoma
line upon phagocytosis of living bacteria (Malaviya et al., 1996).
Costimulatory molecules of the B7 family and the TNF-TNFR
families (e.g., 4-1BB and 4-1BBL) were identified on mouse
bone marrow-derived MCs (BMMCs) and human primary MCs
(Kashiwakura et al., 2004; Nakae et al., 2006). In vivo, MCs
modulate T cell responses in murine experimental autoimmune
encephalomyelitis (EAE), the standard animal model for multiple
sclerosis, in which both CD8+ T cells and MCs are recognized
key players (Secor et al., 2000; Tanzola et al., 2003; Gregory
et al., 2005; Sayed et al., 2008).
These findings suggested, but did not prove, that MCs can
interact with T cells in an antigen-specific manner. Here, we
show that MCs induce CD8+ T cell activation and proliferation,
cytokine secretion, and cytotoxicity in an antigen-dependent
manner and that, vice versa, this interaction also modulates
MC activities.Immunity 31, 665–676, October 16, 2009 ª2009 Elsevier Inc. 665
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Antigen-Specific Mast Cell-CD8 T Cell CrosstalkFigure 1. MCs Induce Antigen-specific
CD8+ T Cell Activation and Proliferation
In Vitro
(A) BMMCs were pulsed with OVA257-264 peptide
(right panel) or left untreated (left panel) for 2 hr
and stained with an antibody recognizing
OVA257-264 (SIINFEKL) in complex with MHC
class I molecules (H-2Kb). One representative
experiment from three is shown.
(B and C) BMMCs were pulsed with OVA257-264
peptide and cultured with OT-I transgenic CD8+
T cells for 48 hr. As negative control, CD8+
T cells were cultured with B2m/, OVA257-264-
pulsed BMMCs or unpulsed BMMCs (control). As
shown in (B), CD8+ T cell activation was deter-
mined by analysis of surface expression of CD69
and CD25 (upper panel) and CD44 (lower panel)
by flow cytometry. Staining with control isotype-
matched antibodies is shown in bold black lines.
Representative results of six independent experi-
ments are shown. As shown in (C), proliferation
of CD8+ T cells was detected by CFSE dilution.
Representative results of three to five independent
experiments are shown.RESULTS
MCs Present Antigenic Peptides via MHC Class I
We first tested whether MCs are able to take up exogenous
peptides, to generate complexes with MHC class I molecules,
and to express them on the cell surface (Porgador et al., 1997).
Specific complexes of OT-I peptides andMHC class I molecules
(H-2Kb) were indeed recognized by 25-D1.16 antibodies on the
surface of BMMCs after preincubation with the model antigenic
peptide (OVA257-264, SIINFEKL) (Figure 1A). This was not seen on
BMMCs without peptide preincubation.
In order to probewhetherMCs induceCD8+ T cell responses in
an antigen-dependent manner, we cocultured OVA257-264-
loaded BMMCs with T cell receptor- (TCR-) transgenic (OT-I),
purified CD8+ T cells at various MC:CD8+ T cell ratios. CD8+
T cell activation was analyzed by flow cytometry. After 48 hr,
antigen-pulsedMCsactivatedCD8+ T cells (Figure 1B), as shown
by a marked upregulation of the T cell activation markers CD69,
CD25, and CD44 on CD8+ T cells. All three T cell activation
markers showed the same dynamics with maximal upregulation
noted at a 1:2 ratio of MC:CD8+ T cells. However, even at
a much lower ratio of MC:CD8+ T cells (1:10), up to 90% ± 4%
of CD8+ T cells displayed an activated phenotype (n = 6). The
lowest tested ratio of MC:CD8+ T cells = 1:100 still sufficed to
induce antigen-specific activation of 29% ± 9% of the CD8+
Tcells (n =6) (Figure 1B). Thus,MCsare highly effective activators
of CD8+ T cells in vitro. For subsequent experiments, the
MC:CD8+Tcell ratio of 1:10wasselected, unless indicatedother-
wise. When MCs were cultured with CD8+ T cells in the absence
of OVA257-264, no CD8
+ T cell activation was seen (Figure 1B,
control), demonstrating that the MC-induced CD8+ T cell activa-
tion was indeed antigen dependent. In addition, OVA257-264-
pulsed BMMCs failed to activate primary purified CD8+ T cells
fromwild-type (WT)mice (data not shown), indicating that activa-
tion of CD8+ T cells by MCs was antigen specific.
To explore whether the observed MC-T cell interaction
depends on the expression of MHC class I on MCs, we used666 Immunity 31, 665–676, October 16, 2009 ª2009 Elsevier Inc.BMMCs derived from beta-2-microglobulin (b2m)-deficient
(B2m/) mice, which do not express functional MHC class I
(Zijlstra et al., 1990), for coculture with CD8+ T cells. Compared
to MHC class I-competent WT MCs, the B2m/ MCs induced
only a minimal activation of CD8+ T cells (4.6% ± 2.1%, n = 4),
with CD69, CD25, and CD44 surface expression as activation
markers (Figure 1B). This indicates that the bulk of CD8+ T cell
activation induced by MCs was due to antigen presentation via
functional MHC class I molecules.
Next, we examined the proliferation of CD8+ T cells by incu-
bating OVA257-264-pulsed MCs with CFSE-labeled OT-I T cells.
Maximal proliferation was detected at a ratio of MC:CD8+
T cells = 1:20, with 92% ± 2% (n = 3) (Figure 1C). At the lowest
tested ratio (1:100), a total of 57% ± 17% (n = 4) of the CD8+
T cells still was in the proliferation pool, whereas no T cell prolif-
eration was detected in the presence of unpulsed MCs or with
B2m/, OVA257-264-pulsed MCs (Figure 1C). Thus, MCs
induced antigen-specific proliferation of CD8+ T cells in an
MHC class I-dependent manner.
MC-CD8+ T Cell Coculture Stimulates Cytokine
and MIP-1a Release by CD8+ T Cells
Because the secretion of defined cytokines is a key effector
function of activated CD8+ T cells, we investigated the cytokine
milieu generated upon antigen-dependent MC-CD8+ T cell con-
tact in vitro. High amounts of IL-2, IFN-g, andMIP-1a (Figure 2A),
as well as lower amounts of TNF-a (0.31 ± 0.18 ng/ml) (n = 3) and
granulocyte-macrophage colony-stimulating factor (GM-CSF)
(0.4 ± 0.12 ng/ml) (n = 3) (data not shown), were measured in
supernatants after antigen-specific MC-CD8+ T cell contact. In
contrast, hardly any or no production of IL-4, IL-5, IL-10, and
IL-12 was seen (data not shown).
IL-2, IFN-g, TNF-a, and MIP-1a were detected intracellularly
in CD8+ T cells upon MC-mediated antigen-dependent activa-
tion (Figure S1 available online), at a percentage of 5.5% ±
2.9% (n = 10), 3.1% ± 1.5% (n = 10), 7.5% ± 0.57% (n = 4),
and 19.3 ± 8.7% (n = 3) respectively. Furthermore, when
Immunity
Antigen-Specific Mast Cell-CD8 T Cell CrosstalkImmunity 31, 6Figure 2. MCs Stimulate Antigen-Specific CD8+ T
Cell Responses
BMMCs were pulsed with OVA257-264 peptide in the pres-
ence or absence of IgE and antigen (Ag) and cultured with
OT-I transgenic CD8+ T cells for 48 hr. CD8+ T cells were
incubated with antigen-pulsed MCs from either WT or
deficient mice (Il2/, Ifng/, Ccl3/) in a 1:10 ratio. As
negative control, CD8+ T cells were cultured with unpulsed
BMMCs.
(A and B) Cytokine concentrations in the coculture super-
natants were determined by ELISA. Mean values ± SD of
three independent experiments are shown. nd, non
detectable.
(C) The cytotoxic potential of CD8+ T cells was measured
by intracellular flow cytometry staining for granzyme B
(gated on CD8+ T cells) (left panel) and cell-surface
expression of LAMP-1 (gated on viable CD3+ T cells) (right
panel). Representative results of three independent exper-
iments are shown. *p% 0.0005.
(D) The antigen-specific CD8+ T cell responses induced by
MCs are cell-contact dependent. BMMCs were pulsed
with OVA257-264 peptide and cultured with CD8
+ T cells
for 48 hr. Direct cell contact between MCs and CD8+
T cells was inhibited by the presence of 0.2 mm or
0.02 mm-anopore membranes, as indicated. Activation of
CD8+ T cells was measured by CD69, CD25 (upper panel),
and CD44 (middle panel) expression by flow cytometry.
Staining with control isotype matched antibodies is shown
in bold black lines. Proliferation of CD8+ T cells was visu-
alized by CFSE dilution (lower panel). Representative
results of three independent experiments are shown.65–676, October 16, 2009 ª2009 Elsevier Inc. 667
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1a-deficient mice were cocultured with OT-I T cells, no signifi-
cant differences in IL-2, IFN-g, and MIP-1a concentrations
were found between the cocultures that used wild-type (WT)
compared to cytokine-deficient BMMCs (Figure 2B). Thus,
activated CD8+ T cells were the primary source of these cyto-
kines.
Fc3RI Stimulation Does Not Affect MC-Mediated CD8+ T
Cell Activation
Next, we investigated whether an Fc3RI-mediated MC activation
would both affect the MC-induced, antigen-specific CD8+ T cell
activation and switch the CD8+ T cell response toward a Th2 cell
type. To address this question, we activated BMMCs via Fc3RI
engagement (IgE+Ag), pulsed them with antigen (OVA257-264),
and subsequently coincubated them with OT-I T cells.
Fc3RI-mediated BMMC degranulation by itself did not affect
CD8+ T cell activation (Figure S2). However, this was associated
with augmented concentrations of IL-6 and IL-13 in the superna-
tants, whereas those of IL-2 and IFN-g remained unchanged
(Figure 2A). Therefore, despite stimulation of a classical MC acti-
vation pathway associated with the production of Th2 cell-type
cytokines, the CD8+ T cell response remained skewed toward
a Th1 cell-type secretory response pattern.
TLR Ligands Enhance MC-Induced CD8+ T Cell
Activation
Mature MCs are most prominently found as resident cells in
peripheral tissue locations where the organism’s chance of
encountering invading pathogens is highest. Indeed, stimulation
of MCs via TLR3 (e.g., by poly IC) mediates CD8+ T cell recruit-
ment in vivo (Orinska et al., 2005). Therefore, we hypothesized
that the exposure of MCs to TLR ligands might modulate the
capacity of MCs to activate CD8+ T cells. We found that
TLR-activation of MCs by LPS or poly I:C enhanced the
capacity of MCs to activate CD8+ T cells and to increase both
MC surface expression of MHC class I molecules and their
IL-2 cytokine secretion (Figure S3). Thus, invading pathogens
may enhance the MHC class-I dependent antigen presentation
of resident MCs.
Contact with Antigen-Specific MCs Enhances CD8+
T Cell Cytotoxic Potential and Degranulation
The amount of granzyme B (Gzmb) in CD8+ T cells upon interac-
tion with antigen-presenting MCs was analyzed by flow cytome-
try as an indicator of CD8+ T cell-mediated cytotoxicity. Intracel-
lular Gzmb expression was increased by 27% ± 9% (n = 9) in
CD8+ T cells after antigen-mediated activation byMCs, a prereq-
uisite for subsequent efficient cytolytic T cell activities (Fig-
ure 2C).
Next, we examined whether CD8+ T cell exocytosis was
enhanced by measuring surface expression of lysosomal-asso-
ciated membrane protein-1 (LAMP-1) on CD8+ T cells after acti-
vation byMCs (Burkett et al., 2005). Indeed, CD8+ T cells showed
markedly increased surface LAMP-1 expression after activation
with antigen-pulsed MCs (Figure 2C). Thus, at least in vitro,
BMMCs increased the cytotoxic potential of CD8+ T cells by
increasing their intracellular content of Gzmb and by inducing
their degranulation in an antigen-specific manner.668 Immunity 31, 665–676, October 16, 2009 ª2009 Elsevier Inc.Direct Cell-Cell Contact Is Essential for Antigen-
Dependent MC-CD8+ T Cell Interaction
To further dissect the mechanistic requirements for antigen-
specific MC-CD8+ T cell interactions, we investigated whether
direct cell-contact is essential for CD8+ T cell activation by
MCs. OVA257-264-pulsed MCs were cultured in free cell contact
with CD8+ T cells or in the presence of two kinds of semiperme-
able membranes: one that allows the passive diffusion of any
soluble factor (0.2 mm anopore membrane) or one (0.02 mm
membrane) that excludes the diffusion of exosomes. Both types
of membranes completely abrogated the subsequent activation
(upper and middle row) and proliferation (lowest row) of CD8+
T cells. This documented the necessity of direct cell-cell contact
between MCs and CD8+ T cells for activation and proliferation of
CD8+ T cells (Figure 2D). Although our data do not question the
principle that MCs can regulate the phenotype and function of
adaptive immune cells by releasing exosomes loaded with
specificantigens (Skokoset al., 2003), our current results suggest
that soluble factors (including exosomes) alone are insufficient to
induce antigen-specific activation of CD8+ T cells by MCs.
MCs Induce Antigen-Specific CD8+ T Cell Responses
upon Listeria monocytogenes Infection
MCs play a dominant role in various host defense mechanisms
(Metz and Maurer, 2007; Galli et al., 2008). To explore whether
MCs can stimulate CD8+ T cell responses upon infection with
intracellular bacteria, we infected BMMCs with Listeria monocy-
togenes. BMMCs could be infected by L. monocytogenes at
multiplicity of infection rates of 1:1 to 100:1 (Figure S4). To inves-
tigate potential CD8+ T cell responses induced by MCs upon
their infection by L. monocytogenes, we used recombinant
L. monocytogenes-OVA (Foulds et al., 2002).
BMMCs were infected with L. monocytogenes-OVA, extracel-
lular bacteria were killed with gentamycin, and theMCs were co-
incubated with purified OT-I T cells. BMMCs that had been in-
fected with L. monocytogenes-OVA activated CD8+ T cells, as
shown by increased CD69 and CD25 surface expression
(21.6% ± 12.7%, n = 5) (Figure 3A). This was in striking contrast
to L. monocytogenes-infected BMMCs and to untreated
BMMCs (control), which failed to activate the transgenic CD8+
T cells. Similarly, OVA-specific proliferation of the CD8+ T cells
was observed upon coculture with L. monocytogenes-OVA-in-
fected BMMCs (35.0% ± 15.4%, n = 5), but not upon coculture
with L. monocytogenes-infected or untreated BMMCs. Finally,
no activation or proliferation was observed when CD8+ T cells
were cocultured with L. monocytogenes-OVA-infected, B2m/
BMMCs (Figure 3A). Thus, the antigen-specific activation and
proliferation of CD8+ T cells induced by L. monocytogenes-
OVA-infected MCs was MHC class I dependent. These results
demonstrate that MCs can internalize, process, and present
bacterial antigens and thus induce antigen-specific activation
and proliferation of CD8+ T cells.
Peritoneal MCs Induce Antigen-Specific Activation
of CD8+ T Cells upon Uptake of OVA In Vitro
In order to verify that primary MCs isolated from the peritoneal
cavity internalize, process, and present antigens and therefore
are capable of modulating CD8+ T cell activities, we incubated
peritoneal MCs with OVA protein for 14 hr and cultured them
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Antigen-Specific Mast Cell-CD8 T Cell CrosstalkwithOT-I transgenicCD8+Tcells. Subsequently, CD8+Tcell acti-
vationwas analyzed by flowcytometry. PeritonealMCs activated
35.3%±18.6%(n=5) of theCD8+Tcells,whereasunpulsedperi-
toneal MCs failed to do so (Figure 3B). Peritoneal macrophages,
used as a positive control, induced a similar activation of CD8+
T cells (26.3%±7.3% [n=6]) compared to the T cell response ob-
tained with peritoneal MCs (data not shown). Thus, primary MCs
may cross-present extracellular antigens and activate CD8+
T cells as efficiently as peritoneal macrophages.
MCs Induce Antigen-Specific Proliferation of Primary
CD8+ T Cells In Vivo
Next, the ability of MCs to induce antigen-specific CD8+ T cell
responses in vivo was examined by adoptive transfer experi-
ments. OVA257-264-pulsed BMMCs were administered intraperi-
toneally to WT mice, then CFSE-labeled, OT-I transgenic CD8+
T cells were injected. Only OVA257-264-pulsed BMMCs induced
Figure 3. MCs Induce Antigen-Specific CD8+ T Cell Responses upon
Processing of OVA
(A) BMMCs were infected with L. monocytogenes-OVA (L.m-OVA) or L. mono-
cytogenes (L.m.) or left untreated (control). As additional negative control,
B2m/ BMMCs were infected with L. monocytogenes-OVA (B2m/).
BMMCs were cocultured with OT-I CD8+ T cells at a ratio of MC:CD8 = 1:2.
Activation of CD8+ T cells wasmeasured by surface expression FACS analysis
of CD69 and CD25. Proliferation of CD8+ T cells was measured by CFSE dilu-
tion. Representative results of two to four independent experiments with at
least four different BMMC cultures are shown.
(B) Peritoneal MCs (PMCs) were sorted by flow cytometry, incubated with OVA
protein, and cocultured with CD8+ T cells at a ratio of MC:CD8 = 1:10. Activa-
tion of CD8+ T cells was measured by flow cytometric analysis of surface
expression of CD69 and CD25. Representative results of three independent
experiments are shown.the proliferation of CD8+ T cells in vivo (p = 0.002) (Figure 4A).
OVA257-264-pulsed BMDCs were used as a positive control
(Figure S5). Because a comparable stimulation of CD8+ T cell
proliferation by the transfer of OVA257-264-pulsed MCs was
observed in WT (30.3% ± 14.9%, n = 6) and in B2m/ mice
(36.5% ± 13.3%, n = 6), this essentially excluded the possibility
that other resident cells that present MHC class I-dependent
antigens markedly influenced the CD8+ T cell proliferative
response. This also underscored the key role of the transferred
MCs for this T cell stimulation.
MCs Induce Antigen-Specific Proliferation of CD8+
T Cell to MOG In Vitro and In Vivo
Next, we tested the efficacy of MCs in regulating a polyclonal
CD8+ T cell response against myelin oligodendrocyte glycopro-
tein (MOG), a key T cell antigen in EAE.MCswere pulsed with the
MOG peptide (MOG35-55) and incubated with MOG-primed
CD8+ T cells in the presence of IL-2. The proliferative response
of MOG-primed CD8+ T cells was tested. MOG35-55-pulsed
MCs induced a substantial, antigen-specific CD8+ T cell prolifer-
ation, as indicated by CFSE dilution of MOG-primedCD8+ T cells
(Figure 4B).
To probe the in vivo relevance of these newly identified MC-T
cell interactions, we employed the EAE model to test whether
MCs affect CD8+ T cell effector functions in a MOG-specific
manner. Wsh/Wsh mice were purposely chosen as MC-deficient
mice strain because they lack MCs but have normal numbers
and ratios of CD4+, CD8+, and CD11c+ cells in the spleen
(Figure S6). WT and Wsh/Wsh mice were immunized with the
MOG35-55 peptide, which contains multiple CD4
+ and CD8+
T cell epitopes (Sun et al., 2001), and spleens were harvested
at day 7 after immunization. Splenocytes were labeled with
CFSE and restimulated ex vivo with MOG35-55.
As shown in Figure 4C, only the CD8+ MOG35-55 T cell subset
fromWsh/Wshmicedisplayedasignificantly reducedproliferation,
whereasMOG35-55-specificCD4
+T cells proliferated comparable
to the ones obtained from immunizedWTmice. Furthermore, the
addition of BMDCs derived from WT mice to the splenocyte
cultures increased the total rate of proliferation in both WT and
Wsh/Wsh spleen cultures (Figure S6), indicating that the impaired
CD8+ T cell proliferation was not caused by an intrinsic CD8+
T cell defect. Taken together, our results provide direct evidence
thatMCs contribute toCD8+ T cell-specific priming in EAE in vivo.
MC Reconstitution in Wsh/Wsh Mice Restores EAE
Clinical Disease Severity and CD8+ T Cell Response
Todirectlyevaluate the invivo roleofMCs inmediatinganantigen-
specific CD8+ T cell immune response against MOG, we elicited
EAE in WT, Wsh/Wsh, and Wsh/Wsh mice reconstituted with WT
BMMCs, assessed the clinical EAE features in all mice (onset of
the clinical symptoms, disease incidence, and clinical score),
and studied EAE immunopathology. Reconstitution of MCs in
the spleen was documented by histochemistry (Figure S7B).
As shown in Figure 5A and Table 1, Wsh/Wsh mice developed
significantly less severe disease than WT mice, as indicated by
lower daily mean clinical scores (p < 0.05) and mean high score
(p < 0.03). However, disease onset, incidence, and lethality
were similar to that of WT controls. These data show that MCs
control disease severity, but are not indispensable for diseaseImmunity 31, 665–676, October 16, 2009 ª2009 Elsevier Inc. 669
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tive transfer of WT BMMCs restored the EAE clinical score
(Figure 5A and Table 1).
Histochemistry of CNS (Figure 5B) and spinal cord (data not
shown) 27 days after immunization revealed a comparable focal
inflammatory cell infiltrationbetweenWTandWTBMMCs-recon-
stituted Wsh/Wsh mice. Twenty-seven days after immunization,
brains and spinal cords were recovered and infiltrating cell
subsets were analyzed by flow cytometry. The absolute numbers
of infiltrating cells (Figure 5C), namely the absolute numbers of
CD8+, but not of CD4+ T cells, were consistently and significantly
reduced inWsh/Wshmice (Figure 5D),whereas reconstitutionwith
WT BMMCs fully restored the CD8+ T cell number. This was
confirmed uponMOG35-55 peptide in vitro rechallenge of spleno-
cytes and measured by IFN-g production (data not shown).
These results demonstrated that BMMCs are not only able to
restore the clinical disease phenotype and severity in MC-defi-
cient mice but also specifically reconstitute the impaired CD8+
T cell response of MC-deficient mice.
CD8+ T Cell-MC Interactions Are Bidirectional
Although we had shown that MCs modulate CD8+ T cell
responses, it remained unclear whether activated CD8+ T cell
Figure 4. MCs Induce Antigen-Specific
CD8+ T Cell Responses In Vitro and In Vivo
(A) A total of 5 3 106 BMMCs were pulsed with
OVA257-264 peptide or left untreated (control) and
injected intraperitoneally into WT C57BL/6 or
B2m/ recipients, as indicated. Twenty-four
hours later, 8 3 106 purified CFSE-labeled, OT-I
CD8+ T cells were transferred intraperitoneally.
Four days later, peritoneal cells were isolated
and analyzed for proliferation of the transferred
CD8+ T cells by CFSE (gated on viable lympho-
cytes). Representative results of three indepen-
dent experiments with at least seven mice per
group are shown.
(B) BMMCs and BMDCs (used for comparison)
were loaded with MOG35-55 peptide and incu-
bated with CD8+ T cells isolated fromMOG immu-
nized mice. IL-2 was added after 3 days of cocul-
ture. Proliferation of CD8+ T cells was measured
by analysis of CFSE dilution. Representative
results of three independent experiments are
shown.
(C) Spleens from MOG35-55-immunized MC-defi-
cient animals and controls were isolated and
analyzed. Splenocytes were incubated with
MOG35-55 peptide. CD8
+ and CD4+ T cell prolifer-
ation was measured by analysis of CFSE dilution.
(n = 8–9). Results are representative of two to three
independent experiments. *p = 0.0011.
can, vice versa, influence MCs activities.
Because activated T cells can induce
maturation of DCs by enhancing surface
expression of MHC and costimulatory
molecules (Bernhard et al., 2000), we
were specifically interested in the effects
of MC-T cell interactions on the expres-
sion of MHC class I and costimulatory molecules by MCs.
Therefore, unpulsed or OVA257-264-pulsed MCs were cocul-
tured with CD8+ T cells for 48 hr and MCs were analyzed for
surface MHC class I expression by flow cytometry. Indeed,
antigen-dependent contact with CD8+ T cells significantly
increased the cell-surface expression of MHC class I on MCs
(Figure 6A).
Furthermore, PCR analysis performed on the cDNA of purified
MCs after antigen-dependent coculture with CD8+ T cells re-
vealed a substantial upregulation of 4-1BB (Figure 6B). This
shows that CD8+ T cells responded to their activation by MCs
not only by upregulating the MHC expression on MCs but also
by stimulating 4-1BB expression on MCs.
MCs secrete biologically active osteopontin (OPN) (Nagasaka
et al., 2008), which plays an important role in regulating T cell
responses during inflammation and infection (Hur et al., 2007).
Therefore, we finally examined whether OPN is produced by
MCs upon contact with CD8+ T cell by measuring the amount
of OPN in the supernatants of MC-CD8+ T cell cocultures
(Figure 6C). The upregulation of OPN by MC-CD8+ T cell cocul-
ture was confirmed on the RNA level (data not shown). These
data suggest that CD8+ T cells induce MHC class I and 4-1BB
expression on MCs as well as the secretion of OPN and support670 Immunity 31, 665–676, October 16, 2009 ª2009 Elsevier Inc.
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Antigen-Specific Mast Cell-CD8 T Cell CrosstalkFigure 5. MC Reconstitution in Wsh/Wsh Mice Restores EAE Severity and Infiltrating CD8+ T Cells
(A) Clinical scores of EAE in wild-type (WT) (n = 9), MC-deficient (Wsh/Wsh) (n = 7), and MC-reconstituted (Wsh/Wsh + BMMC) (n = 14) mice was assigned daily.
Significant differences (p < 0.05) in comparison to Wsh/Wsh group are indicated by asterisks.
(B) Increased cellular infiltrates in Wsh/Wsh + BMMC as compared with Wsh/Wsh mice after EAE induction. Brain sections (thalamus region, day 27) were stained
with hematoxylin eosin (H&E) (upper panel). Infiltrating T cells were detected by staining with CD3-specific antibodies (middle panel), and B cells were detected by
staining with B220-specific antibodies (lower panel). Naive WT and Wsh/Wsh controls displayed no infiltrate (Figure S7). Scale bars represent 200 mm (H&E) and
100 mm (CD3 and B220).
(C) The absolute number of mononuclear cells in CNS and spinal cord was determined by cell counting and trypan blue exclusion. Mean values ± SD are shown.
(D) Detailed analysis of infiltrating lymphocytes into CNS and spinal cord was performed by flow cytometric analysis of surfacemarker staining. Mean values ± SD
are shown. *p < 0.01. All panels represent pooled data from two independent experiments.the concept that MC-CD8+ T cell interactions are bidirectional
(Figure S8).
DISCUSSION
MCs communicate with CD8+ T cells in vivo, namely by inducing
CD8+ T cell chemotaxis (McLachlan et al., 2003; Orinska et al.,2005; Ott et al., 2003). MCs also phagocytose bacteria, process
bacterial antigens, and induce antigen-specific proliferation of
CD8+ T cell lines upon presentation of bacterial-expressed
proteins in vitro (Malaviya et al., 1996). These observations
encouraged us to address whether MCs are capable of inducing
antigen-specific CD8+ T cell responses in vivo and to charac-
terize the underlying mechanisms of MC-CD8+ T cellImmunity 31, 665–676, October 16, 2009 ª2009 Elsevier Inc. 671
Immunity
Antigen-Specific Mast Cell-CD8 T Cell Crosstalkinteractions, the phenotypical and functional consequences of
these interactions, and thus the bidirectionality of this communi-
cation.
Testing two distinct, well-characterized model antigens (OVA
and MOG), we demonstrated here that MCs induce antigen-
specific CD8+ T cell activation and proliferation in vitro and
in vivo. OVA257-264 peptide was utilized as a model antigen for
studying antigen-presenting functions of different cell types
in vitro (Ru¨ckert et al., 2003; Winau et al., 2007).
The antigen-specific CD8+ T cell response after contact with
antigen-pulsed MCs depended on MHC class I-TCR-interac-
tions because MCs with defective MHC class I-presenting func-
tions (i.e., B2m/ MCs) failed to induce substantial CD8+ T cell
activation, and non-TCR-transgenic CD8+ T cells did not
respond to the TCR-specific peptide (OVA257-264) presented by
Table 1. Cumulative Analysis of EAEDisease Parameters inMast
Cell Reconstitution Experiments
Group Incidence Lethality
Mean Day
of Onseta
Mean High
Score
Wild-type 11/11 2/11 9.56 ± 0.18 3.24 ± 0.1b
Wsh/Wsh 9/10 1/10 9.86 ± 0.34 2.7 ± 0.21
Wsh/Wsh + BMMC 15/16 1/16 11.8 ± 0.54 3.26 ± 0.11c
a Results are expressed as the mean (±SEM).
b p < 0.03 as compared with Wsh/Wsh.
c p < 0.02 as compared with Wsh/Wsh.MCs. Theminimal CD8+ T cell response observed after coculture
of CD8+ T cells with OVA257-264-pulsed B2m
/ MCs probably
reflected residual amounts of peptide remaining in the culture
despite extensive washing of the MCs (Schott et al., 2002;
Su et al., 1993). MCs also induced CD8+ T cell effector functions,
such as the production of key T cell cytokines, IFN-g and IL-2,
but none of the Th2 cell-associated cytokines examined (IL-4,
IL-5, and IL-10).
Our data confirm and extend the previous proposal that MCs
play a dual, complex role in regulating the Th1-Th2 cell cytokine
milieu and operate as either predominantly immunosuppressive
or immuno-stimulatory cells, depending on the local signaling
milieu and/or the strength of costimulatory signals and/or
specific signals from the T helper cell environment of MCs (Greg-
ory and Brown, 2006; Stelekati et al., 2007). Our study highlights
that, besides their role as inducers of Th2 cell responses through
the release of IL-4 (Mekori and Metcalfe, 1999), MCs can also
favor Th1 cell responses via interaction with CD8+ T cells and
induction of IFN-g and IL-2 production. The latter is potentiated
via MC prestimulation by TLR ligands but unaffected by Fc3RI
stimulation. This suggests that the stimulation of resident periph-
eral tissue MCs by pathogen-associated TLR ligands may
quickly and effectively promote Th1 cell-type, CD8+ T cell-
dependent anti-infection defense against such pathogens.
These data conformwith the central role of IFN-g in CD8+ T cell
cytolytic activity (Andersen et al., 2006). In addition, we show that
the intracellular content of Gzmb, a key component of theFigure 6. CD8+ T Cells Upregulate MHC Class I
and 4-1BB Expression in MCs and Induce the
Release of OPN In Vitro
OVA257-264-pulsed or unpulsed BMMCs were cocul-
tured with OT-I CD8+ T cells (negative control:
OVA257-264-pulsed BMMCs alone).
(A) After 48 hr, MC surface expression of MHC class I
was analyzed by flow cytometry (open histograms:
control isotype). Histograms show one representative
out of three independent experiments (gated on
viable, CD117+ MCs).
(B) After 48 hr, MCs were isolated and expression of
4-1BB was tested by PCR. Graph shows mean values
of arbitrary units (a.u.) as measured by Optimas Soft-
ware, ±SD (three independent experiments). Contour
plots show surface expression of 4-1BB on MCs
(gated on viable, CD117+ MCs). *p < 0.05.
(C) The concentration of OPN in the supernatants of
MC-CD8+ T cell cocultures was measured by ELISA.
Graph shows mean values ± SEM of four independent
experiments with at least eight different BMMC
cultures.
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after antigen-specific activation by MCs and that CD8+ T cells
degranulate upon antigen presentation by MCs. This concept
is in line with the observation that MC-deficient mice fail to
initiate peptide-specific cytotoxic responses upon TLR7 activa-
tion in vivo (Heib et al., 2007). The MC-dependent CD8+ T cell
responses revealed here could be important for an optimized
host defense, such as protection against intracellular bacteria,
because MCs can induce, e.g., activation and proliferation of
CD8+ T cells upon infection with L. monocytogenes. MCs
mount an early defense against L. monocytogenes by rapid
release of TNF-a and by stimulation of neutrophil migration to
the site of infection (Gekara and Weiss, 2008). Our data suggest
that MCs can, in addition, directly induce effector CD8+ T cell
activities geared at eliminating intracellular pathogens like
Listeria.
We showed that MC-CD8+ T cell interactions also occur
in vivo. Adoptive transfer of antigen-loaded MCs and OT-I trans-
genic CD8+ T cells into B2m/mice served as a model in which
efficient, endogenous MHC-I-restricted antigen presentation is
excluded, thus eliminating a contribution of other resident
APCs to the antigen-dependent CD8+ T cell responses. Further-
more, we provided direct evidence that MCs control disease
severity and contribute to CD8+-specific priming in EAE and
showed that the T cell-proliferation failure is specific to CD8+.
Our finding that MCs control EAE disease severity in Wsh/Wsh
support corresponding findings in W/Wv mice (Secor et al.,
2000; Tanzola et al., 2003; Gregory et al., 2005), but disagree
with the claim that EAE in Wsh/Wsh is indistinguishable from
EAE in WT mice (Bennett et al., 2009).
That MCs can induce the proliferation of primary CD8+ T cells
in an antigen-dependent and antigen-specific manner in vivo
supports the concept that MCs function as crucial switchboard
cells between innate and adaptive immunity and thereby
profoundly modulate adaptive immune responses (Galli et al.,
2005; Stelekati et al., 2007; Sayed et al., 2008) and begs the
question of whether MCs have similar functions in the human
system. Because themajority of MCs resides at peripheral tissue
sites (Marshall, 2004; Galli et al., 2008), upon encountering path-
ogen-related antigens, MCs may internalize the latter to serve as
a strategically placed peripheral reservoir for the presentation of
pathogen-related antigenic peptides. Indeed, MCs latently in-
fected by human immunodeficiency virus (HIV) constitute
a long-lived, inducible peripheral reservoir of viral antigens in hu-
mans (Sundstrom et al., 2007). Some MC subpopulations may
migrate to regional lymph nodes upon infection or inflammatory
stimuli (Dabak et al., 2004; Wang et al., 1998). However, we
hypothesize that, in contrast to DCs, which normally execute
their antigen-presenting functions in regional lymph nodes, it is
primarily resident MCs that play an important, previously unap-
preciated role in the control of CD8+ T cell responses in infec-
tion-prone peripheral tissues.
Our study suggests that MCs constitute part of a growing
family of nonclassical, functionally important tissue- or microen-
vironment-specific APCs that complements ‘‘professional’’
APCs (DCs, B cells, and macrophages), such as epithelial cells,
fibroblasts, and hepatic stellate cells (Unanue, 2007). Further-
more, our data indicate thatMC-CD8+ T cell interactions are bidi-
rectional: CD8+ T cells also enhance surface MHC class I andinduce 4-1BB expression on MCs as well as the production of
OPN after antigen-dependent interaction.
The upregulation of 4-1BB, a costimulatory molecule that
promotes proliferation and effector functions of T cells (Hurtado
et al., 1995), after antigen-dependent MC contact with CD8+
T cells provides mechanistic pointers. MCs can express 4-1BB
(Nakae et al., 2006), and 4-1BB-mediated stimulation of MCs
enhances cytokine production (Nishimoto et al., 2005). There-
fore, increased 4-1BB expression on MCs may enhance the
required production and release of cytokines and other soluble
factors by MCs. However, it remains to be definitively clarified
whether the upregulation of MHC I and 4-1BB on MCs is
primarily caused by secreted, T cell-derived factors (e.g., IL-2,
IFN-g) and/or by cell-cell contact-dependent mechanisms.
Finally, we showed here that OPN, a key cytokine that supports
T cell survival and responses (Hur et al., 2007) and is produced
by MCs upon Fc3RI stimulation (Nagasaka et al., 2008), is upre-
gulated and secreted by MCs upon antigen-dependent MC-
CD8+ T cell interactions. Therefore, the bidirectional crosstalk
between MCs and CD8+ T cell may not only support CD8+
T cell effector functions and cytotoxicity but also regulate
CD8+ T cell survival.
In summary, we showed that MCs regulate antigen-specific
responses of primary CD8+ T cells in vitro and in vivo in a bidirec-
tional and cell-cell contact-dependent manner. This MC function
is likely to be important in all scenarios in which effector CD8+
T cells are critically involved, e.g., infections with viruses and
other intracellular pathogens and/or CD8+ T cell-dependent
autoimmune diseases such as, e.g., multiple sclerosis, alopecia
areata, and type I diabetes (Gregory et al., 2005; Gilhar et al.,
2007; Sayed et al., 2008). It now deserves systematic scrutiny
whether, in these settings, the stimulation or inhibition of
MC-CD8+ T cell interactions offers a promising new target for
more effective therapeutic management.
EXPERIMENTAL PROCEDURES
Animals
C57BL/6 WT mice were purchased from Charles River (Sulzfeld). TCR-trans-
genic OT-I mice (Hogquist et al., 1994) and Il2/ mice (Schorle et al., 1991)
were bred in the Animal Care Facility of the Research Center Borstel. B2m/
mice (Koller and Smithies, 1989) were kindly provided by F. Winau (MPI for
Infection Biology, Berlin). Ifng/ (B6.129S7-Ifngtm1Ts/J), Ccl3/ (B6.129P2-
Ccl3tm1UNC/J), and Kit W-sh (B6.Cg-KitW-sh/HNihrJaeBsmJ) (Wsh/Wsh) mice were
from Jackson Laboratory. All in vivo animal experiments were conducted
with permission and in accordance with current federal, state, and institutional
guidelines.
Generation of BMMCs and BMDCs
Murine bonemarrowcellswere cultivated in IMDMcompletemediumwith 10%
FCS (Biochrom), 5 ng/ml IL-3 (rIL-3), and 10 ng/ml stem cell factor (rSCF) (both
from R&D) (Huff and Lantz, 1997). After 5 weeks of culture, BMMCs (CD117+
(c-Kit), Fc3RI+, T1/ST2+, CD11c, CD45R/B220, F4/80, and Gr-1) repre-
sented >98% of the total cells. BMDCs were generated by cultivation of
bone marrow cells in the presence of GM-CSF as described (Lutz et al., 1999).
Mast Cell Reconstitution of Wsh/Wsh Mice
Six-week-oldWsh/Wshmicewere reconstitutedwith 43 106wild-type BMMCs
injected intravenously. Four weeks after reconstitution, immunization with
MOG and induction of EAE were performed. MC reconstitution was analyzed
by staining of formalin-fixed spleen sections with Napthol AS-D chloroacetate
(Sigma).Immunity 31, 665–676, October 16, 2009 ª2009 Elsevier Inc. 673
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Cells were resuspended in FACS-buffer (2% newborn calf serum, 0.1% NaN3,
2mMEDTA in PBS), stainedwithmAb against CD33 (145-2C11), CD4 (RM4-5),
CD8a (53-6.7), CD45R/B220 (RA3-6B2), Gr-1 (RB6-8C5), CD11c (HL3), CD11b
(M1/70), CD49b/Pan-NK (DX5), CD69 (H1.2F3), CD25 (PL61), CD44 (IM7),
CD117/c-kit (2B8), Fc3RI (MAR-1), H2-Kb (AF6-88.5) (all from BD PharMingen),
and CD137/4-1BB (17B5), MHC class I OVA peptide (25-D1.16) (eBioscience),
T1/ST2 (DJ8) (Morwell Diagnostics), and F4/80 (MCA497FB) (Serotec) for 20
min at 4 C, and subsequently washed with 1 mg/ml propidium iodide
(Sigma-Aldrich) in FACS buffer. For measuring degranulation of CD8+
T cells, rat anti-mouse LAMP-1 (1D4B) mAb (DSHB, University of Iowa) and
F(ab0)2 anti-rat IgG secondary antibody (Serotec) were used. For staining of
CD137 and H2-Kb on MCs, cells were incubated with anti-CD16/32 (BD Phar-
Mingen) prior to the addition of the mAb for surface staining. Samples were
analyzed with a FACSCalibur flow cytometer (BD Biosciences).
Intracellular flow cytometry staining was performed in accordance with
a standard protocol from eBioscience. After 6 hr of cell culture with 10 mg/ml
brefeldin A (Sigma), cells were washed and surface FACS staining was per-
formed. After fixation and permeabilization, intracellular staining was per-
formed by incubation with mAb against IL-2 (JE96-5H4), IFN-g (XMG1.2),
and TNF-a (MP6-XT22) (BD PharMingen), MIP-1a (R&D Systems), or Gzmb
(16G6) (eBioscience). All plots were gated on propidium iodide-negative
CD8+ T cells.
Purification and Coculture of CD8+ T Cells, MCs, and Macrophages
CD8+ T cells were isolated from lymph nodes of OT-I TCR-transgenic mice by
negative selection with magnetic-associated cell sorting (MACS). Cells were
stained with FITC mAb against CD4, CD45R/B220, CD49b/Pan-NK, CD11c,
CD11b, and F4/80, washed, incubated with magnetic anti-FITC-labeled
microbeads (Miltenyi Biotec), and sorted with autoMACS (Miltenyi Biotec).
The sorting yielded >98% CD8+ T cells.
For purificationofMCsafter the in vitrococulturewithCD8+Tcells,magnetic-
associated positive selection was used. Cells were incubated with biotin-
labeled c-kit specific mAb, washed, incubated with streptavidin-micobeads,
and selected with autoMACS. The purity of the MC fraction was >98%, as
shown by CD117, T1/ST2, and Fc3RI expression, determined by FACS.
Peritoneal cells from WT mice were isolated by peritoneal lavage with 10 ml
of ice-cold 0.9% NaCl solution. Peritoneal mast cells (PMCs) were selected in
a FACS sorter (FACS Aria, BD Biosciences) in accordance with their expres-
sion of CD117 and T1/ST2. Purity of PMCs was >98%, according to toluidine
blue staining.
Primary macrophages were selected from cells of peritoneal lavage by
adherence to tissue type cell culture plates for 2 hr. Nonadherent cells were
washed away and macrophages stimulated in vitro with 20 mg/ml OVA before
the CD8+ T cells at a ratio MF:CD8 1:10 were added.
MCs were incubated with 4 mg/ml OVA257-264 (NeoMPS) for 3 hr or with
100 mg/ml OVA (OVA grade VI, Sigma) for 8 hr at 37C and washed four times.
OVA257-264 was tested for endotoxin activity by Coamatic Chromo-LAL kit
(Hemochrom Diagnostica, Essen, Germany) with a resolution limit of
0.005EU/ml. These were in a range of 0.6-0.7EU/ml corresponding to
40-47 pg/ml. Furthermore, the TLR2 agonistic activity of the OVA257-264
peptide was measured by induction of IL-8 production in cells transiently
transfected with TLR2 as described (Heine et al., 2007), and this was lower
than 0.1 nM TLR2 agonist Pam3CSK4. CD8
+ T cells were plated at a density
of 23 106 cells/ml and BMMCs were added at different ratios. In some exper-
imental conditions, the BMMCs were pretreated overnight with 2 mg/ml of IgE
(SP7, Sigma) before OVA257-264 loading and then the IgE-presensitized
BMMCs were cultured in the presence of Ag 100 ng/ml (DNP-HSA, Sigma).
For proliferation assays, CD8+ T cells were labeled with 3 mMCFSE (Vybrant
CFDA SE. Cell Tracker Kit, Molecular Probes) for 6 min at room temperature.
The reaction was stopped by addition of FCS, cells were washed, and prolif-
eration was measured by FACS 72 hr later.
Concentrations of cytokines were determined by specific ELISAs provided
by R&D Systems.
Infection of BMMCs with Listeria monocytogenes
WT Listeria monocytogenes (strain EGD) or recombinant strain Listeria mono-
cytogenes-OVA (Foulds et al., 2002) were cultured overnight, and bacterial674 Immunity 31, 665–676, October 16, 2009 ª2009 Elsevier Inc.density was determined by absorption at 600 nm. BMMCs were washed
and resuspended in IMDM complete medium without antibiotics, at a concen-
tration of 13 106 cells/ml. Listeria monocytogenes or Listeria monocytogenes
OVA were added at a MOI of 1:1–100:1 for 1 hr at 37C. Next, 50 mg/ml gen-
tamycin (GIBCO-Invitrogen) was added to the BMMCs for 30min, and BMMCs
were washed three times and cocultured with the CD8+ T cells in IMDM
medium containing 10 mg/ml gentamycin.
Adoptive Transfer Experiments
A total of 5 3 106 BMMCs were incubated with 4 mg/ml OVA257-264 for 3 hr at
37C and after four washings were injected intraperitoneally in WT or B2m/
mice. One day later, purified OT-I CD8+ T cells were labeled with CFSE and in-
jected in the peritoneum of recipient mice (8 3 106 cells/mouse). Four days
later, proliferation of transgenic CD8+ T cells was analyzed by CFSE dilution.
EAE Induction, Clinical Score, and Histological Analysis
EAEwas induced inmice by injection subcutaneously in both flanks with a total
of 200 mg of MOG35–55 peptide (MEVGWYRSPFSRVVHLYRNGK) (NeoMPS)
dissolved in PBS emulsified in an equal volume of CFA (Difco) supplemented
with 4 mg/ml Mycobacterium tuberculosis H37RA (Difco). Mice were injected
twice intravenously with 300 ng of pertussis toxin (Calbiochem) administered
on the day of immunization and 48 hr later. Mice were scored daily as follows:
0, no detectable signs of EAE; 0.5, distal limb tail; 1.0, complete limb tail; 1.5,
limb tail and hind-limb weakness; 2, unilateral partial hind-limb paralysis; 2.5,
bilateral partial hind-limb paralysis; 3, complete bilateral hind-limb paralysis;
3.5, complete hind-limb paralysis and unilateral forelimb paralysis; 4, total
paralysis of forelimbs and hind limbs; and 5, death. Immunohistochemical
stainings were carried out as described (Kellner et al., 2009). In brief,
paraffin-embedded sections from brain were stained with hematoxylin eosin
(H&E), giemsa, or immunostaining to T cells (CD3, Dako) and B cells (B220,
E-Bioscience), with horseradish peroxidase-labeled secondary antibodies
(Nichirei) and diaminobenzidine as chromogen. For the preparation of CNS
lymphocytes, mice were perfused through the left cardiac ventricle with
PBS. Afterward, brain and spinal cord were removed and incubated 30 min
in a digestion solution (1 mg/ml collagenase and 0.1 mg/ml DNase from
Sigma-Aldrich). Subsequently, the digested tissue was transferred on a cell
strainer and the RBCs were lysed. CNS mononuclear cells were isolated by
a Percoll gradient (1.095 g/ml-1.030 g/ml) from GE-Healthcare. The isolated
cells were washed and resuspended in staining buffer for a direct cell-surface
staining.
Ag Recall Proliferation
Seven days after immunization, mice were sacrificed and spleens were
removed. For the T cell stimulation in vitro, BMDCs and BMMCs were pre-
loaded with 5 mM of MOG35–55 peptide for 2 hr at 37
C and then CFSE-labeled
CD8+ T cells or splenocytes were added at a ratio 1:10. After 3 days, the cells
were washed and cultured for 2 days in 50 ng/ml of recombinant IL-2. The
proliferation was measured by FACS.
Real-Time PCR
RNA was extracted from cells with TRIZOL reagent (GIBCO-Invitrogen). Semi-
quantitative RT-PCR analysis was done with primers as follows: mouse 4-1BB
sense: 50-AGT GTC CTG TGC ATG TGA-30 antisense: 50-AGT TAT CAC AGG
AGT TCTGC-30, mouse OPN sense: 50-GCACCCAGA TCC TAT AGC-30, anti-
sense: 50-TCC GTT GTT GTC CTG ATC-30 and mouse b-actin sense: 50-CTC
CTT AAT GTC ACG CAC GAT TTC-30, antisense: 50-GTG GGG CGC CCC
AGG CAC CA-30. The number of cycles in the RT-PCR was 30.
Statistical Analysis
Data are represented as mean ± standard deviation (SD) or standard error of
mean (SEM) as indicated. Statistical significance was tested by Student’s t
test for unpaired samples. A p value of < 0.05 was considered as statistically
significant.
SUPPLEMENTAL DATA
Supplemental Data include eight figures and can be found with this article on-
line at http://www.cell.com/immunity/supplemental/S1074-7613(09)00409-9.
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